z-logo
open-access-imgOpen Access
Therapeutic hypothermia after cardiac arrest during living-donor liver transplant surgery
Author(s) -
Jaesik Park,
Ju Eun Kwak,
Yun Jeong Cho,
Ho Joong Choi,
Hyo-Sang Choi,
Min Suk Chae,
Chul Soo Park,
Jong Ho Choi,
Sang Hyun Hong
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000022513
Subject(s) - medicine , hypothermia , anesthesia , liver transplantation , cardiopulmonary resuscitation , resuscitation , cirrhosis , transplantation , bispectral index , surgery , sedation
Rationale: Therapeutic hypothermia is an effective medical treatment for neurological recovery after cardiac arrest. Here, we describe a case of successful mild therapeutic hypothermia after cardiac arrest during living-donor liver transplantation. Patient concerns: A 54-year-old woman with alcoholic liver cirrhosis was admitted for living-donor liver transplantation. Cardiac arrest occurred during the anhepatic phase. After cardiopulmonary resuscitation, spontaneous circulation returned, but the bispectral index level remained below 10 until the end of surgery. Diagnoses: Neurological injury caused by global cerebral hypoperfusion was suspected. Interventions: The patient was treated with mild therapeutic hypothermia for 24hours after resuscitation targeting a core body temperature of 34°C with surface cooling using ice bags. Outcomes: The patient recovered consciousness about 22 hours after the event. However, she showed symptoms of delirium even when discharged. At the 3-month follow-up exam, she showed no specific neurological complications. The transplanted liver showed no problems with regeneration. Lessons: Mild therapeutic hypothermia may be safely adopted in cases of cardiac arrest in liver transplant patients and is beneficial for neurological recovery.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here